N. Galie (Bologna, Italy), G. Simonneau (Le Kremlin-Bicêtre, France)
Long-term safety and efficacy of imatinib in pulmonary arterial hypertension M. Hoeper, R. Barst, N. Galie, P. Hassoun, N. Morrell, A. Peacock, G. Simonneau, V. Tapson, F. Torres, D. Lawrence, D. Quinn, H.A. Ghofrani (Hanover, Giessen, Germany; New York, Baltimore, Durham, Dallas, Cambridge, United States Of America; Bologna, Italy; Cambridge, Glasgow, Horsham, United Kingdom; Orsay, France)
| |
Management of chronic thromboembolic pulmonary hypertension (CTEPH): A physician-based perception study H. Tiede, B. Hinzmann, N. Bawden, I. Preston (Giessen, Berlin, Germany; London, United Kingdom; Boston, United States Of America)
| |
The anti-proliferative effects of apelin on pulmonary adventitial fibroblasts L. Brash, C. Church, R. Wadsworth, A. Peacock, D. Welsh (Glasgow, United Kingdom)
| |
Hemodynamics and response to therapy of pulmonary hypertension in patients with interstitial lung disease: Preliminary results of the "HYPID" prospective study V. Cottin, M. Reynaud-Gaubert, J. Traclet, D. Montani, H. Nunes, B. Wallaert, B. Camara, C. Khouatra, D. Launay, S. Marchand-Adam, D. Israel-Biet, R. Magnier, L. Tétu, S. Zeghmar, L. Kiakouama, M. Humbert, J.F. Cordier (Lyon, Marseille, Clamart, Bobigny, Lille, Grenoble, Tours, Paris, Caen, Toulouse, France)
| |
Cicletanine in pulmonary arterial hypertension (PAH): Results from a phase 2 randomized placebo-controlled trial A. Waxman, R. Oudiz, S. Shapiro, M. Gomberg-Maitland, A. Keogh, D. Badesch, R. Frantz, C.G. Elliott, H. Gillies, G. Walker (Boston, Torrance, Los Angeles, , Denver, Rochester, Murray, Foster City, United States Of America; Sydney, Australia)
| |
Pulmonary hypertension due to alveolar hypoventilation: Functional impact and improvement of haemodynamics and exercise capacity under non-invasive positive pressure ventilation M. Held, J. Walthelm, S. Baron, C. Roth, B. Jany (Würzuburg, Germany)
| |
Improved right ventricular function after substantial afterload reduction in patients with pulmonary arterial hypertension M. van de Veerdonk, T. Marcus, H.J. Bogaard, N. Westerhof, A. Vonk-Noordegraaf (Amsterdam, Netherlands)
| |